Discontinued operations (including Specialty Chemicals)

The separation of Specialty Chemicals, via a private sale or legal demerger, is on track for April 2018. The Specialty Chemicals business is reported as discontinued operations.

Discontinued operations and held for sale

The results and cash flows from discontinued operations in 2017, as well as 2016, and the assets and liabilities held for sale at December 31, 2017, almost completely relate to the Specialty Chemicals business.

In April 2017, AkzoNobel officially announced its decision to separate the Specialty Chemicals business, thereby creating two focused, high performing businesses – Paints and Coatings, and Specialty Chemicals. At the EGM of November 30, 2017, shareholders approved the proposed separation of the Specialty Chemicals business from AkzoNobel through a private sale or a legal demerger, expected to be completed in 2018. The Specialty Chemicals business consists of the Specialty Chemicals Business Area and certain other assets and liabilities and income and expenses which are directly attributed to the Specialty Chemicals business from the Other activities. As from December 22, 2017, the Specialty Chemicals business is classified as held for sale and discontinued operations, therefore the consolidated statement of income for 2017, as well as for 2016, have been represented to show the results of the Specialty Chemicals business as discontinued.

Revenue

Revenue of discontinued operations consists of revenue of Specialty Chemicals and eliminations of intercompany revenue.

EBIT

Full-year EBIT was up 8% at €620 million (2016: €574 million).

  • In Specialty Chemicals, EBIT was up 10%, with higher volumes and cost control more than compensating for raw material price inflation and adverse currencies
  • EBIT in Other activities decreased, mainly due to some one-off items positively impacting the previous year

Operating income

Full-year operating income was negatively impacted by identified items totaling €49 million, mainly related to the costs of the separation of Specialty Chemicals and legal items. In 2016, operating income was positively impacted by identified items relating to the sale of assets.

Summary of financial outcomes discontinued operations

Fourth quarter

 

January-December

2016 1

2017

∆%

in € millions

2016 1

2017

∆%

1

Represented to present the Specialty Chemicals business as discontinued operations

2

ROS% = EBIT/Revenue. ROI (in %) = 12 months EBIT/12 months average invested capital

1,165

1,222

5

Revenue

4,763

4,963

4

86

126

47

EBIT

574

620

8

85

102

20

Operating income

596

571

(4)

7.4

10.3

 

ROS% 2

12.1

12.5

 

7.3

8.3

 

OPI margin%

12.5

11.5

 

 

 

 

 

 

 

 

 

 

 

Average invested capital

3,623

3,624

 

 

 

 

ROI (in %) 2

15.8

17.1

 

 

 

 

 

 

 

 

128

122

 

Capital expenditures

356

363

 

 

 

 

Net cash from operating activities

714

691

 

 

 

 

 

 

 

 

52

47

 

Profit for the period

436

393

 

 

 

 

Number of employees

9,800

9,700

 

Profit and loss discontinued operations

Fourth quarter

 

January-December

2016 1

2017

in € millions

2016 1

2017

1

Represented to present the Specialty Chemicals business as discontinued operations

1,165

1,222

Revenues

4,763

4,963

(1,090)

(1,122)

Expenses

(4,167)

(4,402)

75

100

Profit before tax

596

561

(23)

(53)

Income tax

(160)

(168)

52

47

Profit for the period

436

393

EBIT of discontinued operations

Fourth quarter

 

January-December

2016 1

2017

∆%

in € millions

2016 1

2017

∆%

1

Represented to present the Specialty Chemicals business as discontinued operations

118

165

40

Specialty Chemicals

629

689

10

(32)

(39)

 

Other activities/eliminations

(55)

(69)

 

86

126

47

Total

574

620

8

Operating income of discontinued operations

Fourth quarter

 

January-December

2016 1

2017

∆%

in € millions

2016 1

2017

∆%

1

Represented to present the Specialty Chemicals business as discontinued operations

118

165

40

Specialty Chemicals

629

689

10

(33)

(63)

 

Other activities/eliminations

(33)

(118)

 

85

102

20

Total

596

571

(4)

Assets and liabilities held for sale

in € millions

December 31, 2017

Intangible assets

787

Property, plant and equipment

2,266

Financial non-current assets

205

Inventories

503

Receivables

840

Assets held for sale

4,601

Non-current liabilities

765

Short-term borrowings

341

Current payables

1,090

Liabilities held for sale

2,196

Cash flows from discontinued operations

in € millions

2016 1

2017

1

Represented to present the Specialty Chemicals business as discontinued operations

Net cash from operating activities

714

691

Net cash from investing activities

(343)

(354)

Net cash from financing activities

(9)

323

Cash flows from discontinued operations

362

660